Concepedia

Author

Jeffrey T. Czaplinski

Brigham and Women's Hospital

Also Known As

J T Czaplinski, J. T. Czaplinski, J.T. Czaplinski, Jeffrey Czaplinski, Jeffrey T. Czaplinski

23

Publications

472

Citations

6

H-Index

28

Concepts

All Affiliations

Brigham and Women's HospitalDana-Farber Cancer InstituteHarvard UniversityBroad Institute
JT

About

Jeffrey T. Czaplinski is an author at Brigham and Women's Hospital specializing in pathology, medicine, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

188

2

Cell Biology

4

4

188

3

Pathology

4

4

188

4

Cellular Physiology

1

1

37

5

Immunology

1

1

37

Jeffrey T. Czaplinski

×

6

Publications

458

Citations

6

H-Index

YearCitations

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

César Serrano, Adrián Mariño‐Enríquez, Derrick L. Tao,

British Journal of Cancer

2019

159

Antiproliferative Effects of CDK4/6 Inhibition in <i>CDK4</i> -Amplified Human Liposarcoma <i>In Vitro</i> and <i>In Vivo</i>

Yi-Xiang Zhang, Ewa Sicińska, Jeffrey T. Czaplinski,

Molecular Cancer Therapeutics

2014

111

Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma

Robert Nakayama, Yi-Xiang Zhang, Jeffrey T. Czaplinski,

Oncotarget

2016

71

<i>CDKN2A</i>/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans

Grant Eilers, Jeffrey T. Czaplinski, Mark Mayeda,

Molecular Cancer Therapeutics

2015

51

c‐Jun promotes cell migration and drives expression of the motility factor <scp>ENPP2</scp> in soft tissue sarcomas

Stefano Sioletic, Jeffrey T. Czaplinski, Lan Hu,

The Journal of Pathology

2014

37

Genome-wide functional screening identifies CDC37 as a crucial HSP90-cofactor for KIT oncogenic expression in gastrointestinal stromal tumors

Adrián Mariño‐Enríquez, W-B Ou, Glenn S. Cowley,

Oncogene

2013

29

Page 1